Does magnetic resonance represent the gold-standard of imaging for the follow-up of arthritis?;La risonanza magnetica rappresenta il futuro del follow-up delle artriti?

Reumatismo

Volumn 58, Issue 4, 2006, Pages 245-252

  Cimmino, Marco A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE;

ANKYLOSING SPONDYLITIS; BONE LESION; BONE RADIOGRAPHY; CLINICAL EXAMINATION; COST EFFECTIVENESS ANALYSIS; DISEASE ACTIVITY; DRUG EFFICACY; FOLLOW UP; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; STANDARDIZATION; SYNOVIUM; THERAPY EFFECT; ARTHRITIS; BONE DISEASE; DISEASE COURSE; EDEMA; EDITORIAL; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BONE DISEASES; DISEASE PROGRESSION; EDEMA; HUMANS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; SPONDYLITIS, ANKYLOSING;

EID: 34247099724     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
2. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 729-40.
3. Lassere M, McQueen F, Østergaard M, Conaghan P, Shnier R, Peterfy C, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Exercise 3: an international multicenter reliability study using the RA-MRI score. J Rheumatol 2003; 30: 1366-75.
4. The EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005; 64 (Suppl. 1): i1-i55.
5. Østergaard M, Hansen M, Stoltenberg M, Gideon P, Klarlund M, Jensen KE, et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 918-29.
6. Cimmino MA, Innocenti S, Livrone F, Magnaguagno F, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum 2003; 48: 1207-13.
7. Parodi M, Silvestri E, Garlaschi G, Cimmino MA. How normal are the hands of normal controls? A study with dedicated magnetic resonance imaging. Clin Exp Rheumatol 2006; 24: 134-41.
8. Zanetti M, Bruder E, Romero J, Hodler J. Bone marrow edema pattern in osteoarthritic knees: correlation between MR imaging and histologic findings. Radiology 2000; 215: 835-40.
9. Plenk Jr H, Hofmann S, Eschberger J, Gstettner M, Kramer J, Schneider W, et al. Histomorphology and bone morphometry of the bone marrow edema sindrome of the hip. Clin Orthoped Rel Res 1997; 334: 73-84.
10. Sharp JT, Gardner JC, Bennett EM. Computer-based methods for measuring joint space and estimating erosion volume in the finger and wrist joints of patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 1378-86.
11. Østergaard M, Hansen M, Stoltenberg M, Jensen KE, Szkudlarek M, Pedersen-Zbinden B, et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum 2003; 48: 2128-31.
12. McQueen F, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, et al. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using Xrays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001; 60: 859-68.
13. Palosaari K, Vuotila J, Takalo R, Jartti A, Niemelä RK, Karjalainen A et al. Bone oedema predicts erosive progression on wrist MRI in early RA - a 2-yr observational MRI and NC scintigraphy observational study. Rheumatology 2006; e-pub ahead of print.
14. Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, et al. Elucidation of the relationship between synovitis and bone damage. A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003; 48: 64-71.
15. Bird P, Kirkham B, Portek I, Shnier R, Joshua F, Edmonds J, et al. Documenting damage progression in a two-year longitudinal study of rheumatoid arthritis patients with established disease (The DAMAGE study cohort). Arthritis Rheum 2004; 50: 1383-9.
16. Quinn MA, Conaghan PG, O'Connor PJ, Karim Z, Greenstein A, Brown A, et al. Very early treatment with infliximab in additino to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal. Arthritis Rheum 2005; 52: 27-35.
17. Argyropoulou MI, Glatzouni A, Voulgari PV, Xydis VG, Nikas SN, Efremidis SC, et al. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab. Bone Joint Spine 2005; 72: 557-61.
18. Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Rigway JP, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002; 46: 366-72.
19. Gandy SJ, Brett AD, Dieppe PA, Keen MC, Maciewicz RA, Taylor CJ, et al. Measurement of cartilage volumes in rheumatoid arthritis using MRI. Br J Radiol 2005; 78: 39-45.
20. McQueen F, Passere M, Østergaard M. Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006; 8: 207 (doi:10.1186/ar1934).
21. D'Auria MC, Scarpa R, Parodi M, Silvestri E, Garlaschi G, Cimmino MA. La risonanza magnetica delle articolazioni periferiche nell'artrite psoriasica. Reumatismo in press.
22. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Dannsekiold-Samsøe, Boesen J, Bliddal H. Magnetic resonance imaging of the wrist and finger joints in patient with inflammatory joint diseases. J Rheumatol 2001; 28: 2193-200.
23. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Dannsekiold-Samsøe, et al. MRI of the wrist and finger joints in inflammatory joint diseases at 1-year interval: MRI features to predict bone erosions. Eur Radiol 2002; 12: 1203-10.
24. Walzer UA Uhl M, Weiner SM, Warnatz K, Lange-Nolde A, Dertinger H, et al. Analgesic and disease modifying effects of interferential current in psoriatic arthritis. Rheumatol Int 2006; 2006; 26: 904-7.
25. Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[f-18]-fluoro-2-deoxy-d-glucose. Radiology 1995; 196: 647-55
26. Antoni C, Dechant C, Lorenz H-M, Hanns-Martin Lorenz PD, Wendler J, Ogilvie A, Lueftl M, et al. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Care Res 2002; 47: 506-12.
27. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreiman M, Hempfing A, et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006; 8: R143.
28. Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with ifliximab: evaluation of a new scoring system. Arthritis Rheum 2003; 48: 1126-36.
29. Braun J, Baraliakos X, Golder W, Hermann K-G, Listing J, Brandt J, et al. Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resoance imaging using established and new scoring systems. Ann Rheum Dis 2004; 63: 1046-55.
30. Sieper J, Baraliacos X, Listing J, Brandt J, Haibel H, Rudwaleit M, et al. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after two years of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology 2005; 44: 1525-30.
31. Rudwaleit M, Baraliacos X, Listing J, Brandt J, Sieper J, Braun J. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and un-differentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis 2005; 64: 1305-10.
32. Conaghan PG, McQueen FM, Peterfy CG, Lassere MN, Ejbjerg B, Bird P, et al. The evidence for magnetic resonance imaging as an outcome measure in proof-of-concept rheumatoid arthritis studies. J Rheumatol 2005; 32: 2465-9.
33. McQueen FM, Crebbe J, Stewart N, Cimmino MA, Silvestri E, Garlaschi G. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis: comment on the article by Cimmino et al. Arthritis Rheum 2004; 50: 674-6.
34. Ejbjerg B, Narvestad E, Jacobsen S, Thomsen HS, Østergaard M. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann Rheum Dis 2005; 64: 1280-7.
35. Peterfy CG. Magnetic resonance imaging of rheumatoid arthritis: the evolution of clinical applications through clinical trials. Semin Arthritis Rheum 2001; 30: 375-96.